Nichi-Iko Pharmaceutical and Sagent Pharmaceuticals, a Nichi-Iko Group Company (“Sagent”), a leader of specialty pharmaceutical products with an emphasis on the injectable market, announced that Sagent has acquired an FDA-approved manufacturing site in Raleigh, North […]
The Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with German biopharmaceutical firm CureVac that is developing a transportable automated messenger RNA (mRNA) vaccine printing platform. The RNA Printer platform is intended to rapidly produce […]
A clinical trial held in the UK in patients with Parkinson’s Disease showed that it could be possible to restore damaged neurons by boosting the levels of a naturally-occurring protein called Glial Cell Line Derived […]
Immunotherapy company NantKwest has partnered with ProMab Biotechnologies with the aim of developing a select next generation targeted natural killer (NK) cell therapy. This will initially be for the treatment of multiple myeloma, a type […]
Shield Therapeutics said that its oral ferric iron therapy Feraccru proved to be non-inferior to Ferinject (ferric carboxymaltose or FCM), a widely used intravenously delivered iron replacement therapy, in the AEGIS-H2H non-inferiority study. The phase […]